Page last updated: 2024-11-12

fluxapyroxad

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

fluxapyroxad: carboxamide; succinate dehydrogenase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

fluxapyroxad : An aromatic amide obtained by formal condensation of the carboxy group of 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid with the amino group of 3',4',5'-trifluorobiphenyl-2-amine. Used to control a number of cereal fungal pathogens including those belonging to the Ascomycetes, Basidiomycetes and Zygomycetes families. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16095400
CHEBI ID83113
SCHEMBL ID167627
MeSH IDM000598194

Synonyms (35)

Synonym
n-(2-(3,4,5-trifluorophenyl)phenyl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide
3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro[1,1'-biphenyl]-2-yl)-1h-pyrazole-4-carboxamide
n-(3',4',5'-trifluorobiphenyl-2-yl)-1-methyl-3-difluoromethyl-1h-pyrazole-4-carboxamide
n-(3',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxamide
3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluorobiphenyl-2-yl)-1h-pyrazole-4-carboxamide
3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide
fluxapyroxad
907204-31-3
fluxapyroxad [iso]
3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro(1,1'-biphenyl)-2-yl)-1h-pyrazole-4-carboxamide
unii-7u8p4nar2s
7u8p4nar2s ,
xemium
SCHEMBL167627
CHEBI:83113
DTXSID6058215
AKOS027322014
3-(difluoromethyl)-1-methyl-n-[2-(3,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide
fluxapyroxad, pestanal(r), analytical standard
fluxapyroxad 100 microg/ml in acetonitrile
Z1552164593
EX-A1676
3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro-[1,1'-biphenyl]-2-yl)-1h-pyrazole-4-carboxamide ,
AS-36599
Q15632875
mfcd22373628
3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluorobiphenyl-2-yl)-1h-pyrazole-4-carboxamide; xemium
3-(difluoromethyl)-1-methyl-n-(3 inverted exclamation marka,4 inverted exclamation marka,5 inverted exclamation marka-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide
HY-135549
CS-0113442
1h-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluoro[1,1'-biphenyl]-2-yl)-
AC-36586
3-(difluoromethyl)-1-methyl-n-{3',4',5'-trifluoro-[1,1'-biphenyl]-2-yl}-1h-pyrazole-4-carboxamide
EN300-264529
1ST000820

Research Excerpts

Overview

Fluxapyroxad (FLU) is a succinate dehydrogenase inhibitor (SDHI) fungicide. It protects crops from fungal diseases, but it has been identified as toxicants to aquatic organisms.

ExcerptReferenceRelevance
"Fluxapyroxad (FLU) is a succinate dehydrogenase inhibitor that protects crops from fungal diseases, however, it has been identified as toxicants to aquatic organisms. "( Effects of embryonic exposure to fluxapyroxad on zebrafish (Danio rerio) ocular development.
Chen, X; Li, W; Qiu, T; Wang, L; Xiao, P, 2022
)
2.45
"Fluxapyroxad (FLU) is a succinate dehydrogenase inhibitor (SDHI) fungicide used in controlling crop diseases. "( Transcriptional responses of fluxapyroxad-induced dysfunctional heart in zebrafish (Danio rerio) embryos.
Guo, S; Li, W; Miao, N, 2022
)
2.46
"Fluxapyroxad (FLU) is a broad spectrum pyrazole-carboxamide SDHI fungicide and its potential impacts on fish embryonic development are unknown."( Fluxapyroxad induces developmental delay in zebrafish (Danio rerio).
Li, W; Liu, X; Wu, Y; Yuan, M, 2020
)
2.72
"Fluxapyroxad is a broad-spectrum and high-efficiency succinate dehydrogenase inhibitor fungicide that can control plant fungal pathogens on many crops. "( Toxic effects and potential mechanisms of Fluxapyroxad to zebrafish (Danio rerio) embryos.
Chen, J; Cui, F; Lin, F; Lin, H; Yuan, J, 2021
)
2.33

Toxicity

ExcerptReferenceRelevance
" In this study, zebrafish embryos were exposed to fluxapyroxad to investigate the toxic effects and potential mechanisms of fluxapyroxad."( Toxic effects and potential mechanisms of Fluxapyroxad to zebrafish (Danio rerio) embryos.
Chen, J; Cui, F; Lin, F; Lin, H; Yuan, J, 2021
)
1.14
" Despite its increasing use in modern agriculture and long-term retention in the environment, the potentially toxic effects of Flu in vivo, especially on neurodevelopment, remain under-evaluated."( The adverse effects of fluxapyroxad on the neurodevelopment of zebrafish embryos.
Chen, J; Chen, S; Chen, Y; Li, H; Qiu, Y; Xia, S; Yu, H; Zhang, J; Zhao, Y; Zhu, J, 2022
)
1.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitorAn EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor that interferes with the action of succinate dehydrogenase (quinone), EC 1.3.5.1.
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
aromatic amideAn amide in which the amide linkage is bonded directly to an aromatic system.
biphenylsBenzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.
pyrazoles
trifluorobenzeneAny member of the class of fluorobenzenes carrying three fluorine substituents at unspecified positions.
anilide fungicideAny amide fungicide whose structure contains an anilide group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (42.42)24.3611
2020's19 (57.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.08 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index79.99 (26.88)
Search Engine Supply Index2.29 (0.95)

This Compound (47.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (96.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]